What is Hypertension Drugs Market Scope?
Hypertension is defined as a condition in which the arteries in the heart have continuously increased pressure. It is also known as high blood pressure (HBP). According to the 2017 American Heart Association, high blood pressure is a blood pressure condition greater than 130 and 80 millimetres of mercury (mmHg). The measurement of blood pressure is expressed as; systolic pressure and diastolic pressure. Hypertension is a serious health condition that increases the risk of coronary artery disease and ischemic heart disease, which are the leading causes of death worldwide. Hypertension also leads to various other health problems such as heart failure, kidney dysfunction, retinal haemorrhage, and visual impairment. The main purpose of high blood pressure drugs is to lower and control high blood pressure to protect organs like the brain, heart, and kidneys.
The Hypertension Drugs market study is being classified by Type (Systemic Hypertension Drugs and Pulmonary Hypertension Drugs), by Application (Hospital Use, Clinic Use and Others) and major geographies with country level break-up.
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies Research Analyst at AMA predicts that Players from United States & Japan will contribute to the maximum growth of Global Hypertension Drugs market throughout the predicted period.
Takeda Pharmaceutical Co. Ltd. (Japan), Johnson & Johnson (United States), Sun Pharmaceutical Industries (India), Bausch Health Companies Inc. (Canada), Pfizer Inc. (United States), Novartis AG (Switzerland), Daiichi Sankyo Co. Ltd. (Japan), LG Life Sciences (South Korea), Takeda Pharmaceuticals (Japan) and AstraZeneca plc (United Kingdom) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Sanofi SA (France), Bayer AG (Germany), Boehringer Ingelheim GmbH (Germany), Merck & Co. (United States) and Lupin Pharmaceuticals (India).
Analyst at AMA have segmented the market study of Global Hypertension Drugs market by Type, Application and Region.
On the basis of geography, the market of Hypertension Drugs has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
In February 2019, after eight years of effort, Tong Ren Tang developed Yufeng Ningxin Tablet, a flagship for high blood pressure, and received marketing approval as an OTC botanical drug in the EU. Given the high standards and strict procedures of the EU, Tong Ren Tang improved accordingly with the help of experts from the Netherlands. This was the key to joining the EU market following its approval by the Drug Evaluation Board of the Netherlands.
Influencing Market Trend
- Huge Funding In R&D and Various Initiatives by Government
- Rapid Urbanization and Globalization, Human Health Is Being Adversely Affected
- Change In Lifestyle and Elevated Stress Levels
- An Increase in Geriatric Population
- Advancement in Technology, And Low Prices of the Drugs
- Improved Awareness among People Regarding Hypertension and Its Available Treatment Options
- Availability of Alternative Therapies
- Relative Side Effects by the Use of Hypertension Drug
Key Target AudienceNew Entrants/Investors, Analysts and Strategic Business Planners, Hypertension Drugs Manufacturer, Government Regulatory and Research Organizations and End-Use Industry
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research & Media features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.